Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Tirzepatide (Mounjaro, Zepbound) is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, though these medications are often collectively referred to as incretin-based therapies
It is also possible and included within the invention that the PDE-5 inhibitor is administered to maintain a steady-state plasma concentration and PT-141 is administered at anytime thereafter
Importantly, tirzepatide carries a boxed warning and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Follow Treatment Plans: Its important for patients to follow their treatment plans, including taking medications as prescribed and making lifestyle changes recommended by their doctors
US$ 24.64
US$ 23.13
US$ 22.41
